MicroRNA-29b mediates altered innate immune development in acute leukemia.
about
Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.Kinetics of Cytotoxic Lymphocytes Reconstitution after Induction Chemotherapy in Elderly AML Patients Reveals Progressive Recovery of Normal Phenotypic and Functional Features in NK Cells.Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.MicroRNA-29c Prevents Pulmonary Fibrosis by Regulating Epithelial Cell Renewal and Apoptosis.MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer.Dependence of innate lymphoid cell 1 development on NKp46.
P2860
MicroRNA-29b mediates altered innate immune development in acute leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-29b mediates altered innate immune development in acute leukemia.
@en
MicroRNA-29b mediates altered innate immune development in acute leukemia.
@nl
type
label
MicroRNA-29b mediates altered innate immune development in acute leukemia.
@en
MicroRNA-29b mediates altered innate immune development in acute leukemia.
@nl
prefLabel
MicroRNA-29b mediates altered innate immune development in acute leukemia.
@en
MicroRNA-29b mediates altered innate immune development in acute leukemia.
@nl
P2093
P2860
P356
P1476
MicroRNA-29b mediates altered innate immune development in acute leukemia.
@en
P2093
Aharon G Freud
Bethany L Mundy-Bosse
Elshafa H Ahmed
Hsiaoyin C Mao
Jianhua Yu
Jordan Cole
Karilyn Larkin
Kathleen McConnell
Michael A Caligiuri
P2860
P304
P356
10.1172/JCI85413
P407
P577
2016-10-24T00:00:00Z